SCHEMBL845508

SCHEMBL845508

Cc1c(O)cccc1Cc1cccc(O)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 1/20 0.56
TRPA1 O75762 2/20 0.54
ATM Q13315 1/20 0.54
MAPT P10636 3/20 0.43
HSD17B10 Q99714 2/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
GABRA1 P14867 2/20 0.42
GABRB2 P47870 2/20 0.42
KEAP1 Q14145 1/20 0.40
IAPP P10997 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
HIF1A Q16665 1/20 0.39
HPGD P15428 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
ADAMTS4 O75173 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29290540 0.86 AMY1A (0.59) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL30375220 0.86 AMY1A (0.59) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL5648473 0.85 BCL2 (0.55) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL29102692 0.84 AMY1A (0.62) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL286623 0.83 PDCD1 (0.55) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL2021799 0.83 GABRA1 (0.58) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL30970850 0.83 GABRA1 (0.58) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL28694834 0.82 AMY1A (0.50) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL7994002 0.81 TRPA1 (0.50) HSPA5TRPA1ATMMAPTHSD17B10
SCHEMBL31317052 0.81 TRPA1 (0.50) HSPA5TRPA1ATMMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof ADEKA CORPORATION (JP) 2026-05-12 US disclosed
EP-4306566-B1 CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE ADEKA CORP (JP) 2026-05-06 EP disclosed
US-12590178-B2 Curable resin composition and method for suppressing curing shrinkage of curable resin composition ADEKA CORPORATION (JP) 2026-03-31 US disclosed
US-12584036-B2 Ink ejection device Konica Minolta, Inc. (JP) 2026-03-24 US disclosed
US-20260022204-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF ADEKA CORPORATION (JP) 2026-01-22 US disclosed
US-12473472-B2 Photocurable adhesive DENSO CORPORATION (JP) 2025-11-18 US disclosed
US-12473470-B2 Photocurable adhesive DENSO CORPORATION (JP) 2025-11-18 US disclosed
US-20250326948-A1 COATING KIT AND METHOD FOR REPAIR AND/OR RECONSTITUTION OF RUBBER AND/OR METAL WORN AREAS BERTECH PANAMA S A (PA) 2025-10-23 US disclosed
US-12435176-B2 Curable resin composition ADEKA CORPORATION (JP) 2025-10-07 US disclosed
US-12435178-B2 Resin composition for fiber-reinforced plastic, and fiberreinforced plastic containing said composition ADEKA CORPORATION (JP) 2025-10-07 US disclosed
US-20040236061-A1 Curing agent composition for epoxy resin ASAHI DENKA CO., LTD. (JP) 2004-11-25 US disclosed
US-6541541-B2 Epoxy resin or polyepoxy compound based on glycidol and a bisphenol compound; use as sizing agent for glass fibers; fiber-reinforced resins resistant to thermal coloring and excellent in physical properties ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2003-04-01 US disclosed
EP-1295857-A1 Aqueous resin composition ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2003-03-26 EP disclosed
US-20020132955-A1 Curing agent composition and curing epoxy resin composition ASAHI DENKA KOGYO KABUSHIKI KAISHA 2002-09-19 US disclosed
US-6451931-B1 REACTION PRODUCT OF AMINE, DIHYDRAZIDE AND POLYISOCYANATE ASAHI DENKI KOGYO KABUSHIKI KAISHA (JP) 2002-09-17 US disclosed
EP-1221453-A1 Curing agent composition and curable epoxy resin composition ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2002-07-10 EP disclosed
US-20020061941-A1 Aqueous resin composition ASAHI DENKA KOGYO KABUSHIKI KAISHA 2002-05-23 US disclosed
JP-2001059010-A O-CRESOL NOVOLAK TYPE EPOXY RESIN WITH HIGH SOFTENING POINT, AND PRODUCTION OF EPOXY RESIN SOLUTION AND EPOXY RESIN COMPOSITION EACH CONTAINING THE SAME AND THE EPOXY RESIN NIPPON KAYAKU CO LTD 2001-03-06 JP disclosed
US-4754063-A COLOR FORMERS FOR PRESSURE OR HEAT SENSITIVE RECORDING MATERIAL CIBA-GEIGY CORPORATION (US) 1988-06-28 US disclosed
US-4687869-A Metal salicylates, process for their preparation and use thereof as color developers in pressure-sensitive or heat-sensitive recording materials CIBA-GEIGY CORPORATION (US) 1987-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof SORD, SUCLA2, SUCLG1 HSPA5 207/4885TRPA1 3272/4885ATM 3890/4885
US-20260022204-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF PHOSPHO1, EBP, CA1 HSPA5 162/4885TRPA1 2893/4885ATM 4408/4885
US-12590178-B2 Curable resin composition and method for suppressing curing shrinkage of curable resin composition SEM1, RER1, JMJD6 HSPA5 1849/4885TRPA1 2339/4885ATM 4418/4885
US-12584036-B2 Ink ejection device ILK, ITGA4, ITGB3 HSPA5 913/4885TRPA1 2961/4885ATM 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.